ethyl stearate has been researched along with Parkinson Disease, Secondary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Chen, L; Huang, J; Li, C; Li, H; Li, X; Lv, J; Miao, J; Ye, S; Yi, L; Zhong, J | 1 |
1 other study(ies) available for ethyl stearate and Parkinson Disease, Secondary
Article | Year |
---|---|
Protective effect of plastrum testudinis extract on dopaminergic neurons in a Parkinson's disease model through DNMT1 nuclear translocation and SNCA's methylation.
Topics: alpha-Synuclein; Animals; Antiparkinson Agents; DNA (Cytosine-5-)-Methyltransferase 1; Dopaminergic Neurons; Hydroxydopamines; Male; Mesencephalon; Neuroprotective Agents; Parkinson Disease, Secondary; PC12 Cells; Plant Extracts; Rats; Rats, Sprague-Dawley; Stearates; Substantia Nigra; Tissue Extracts | 2021 |